Dr Thomas Borody is a prominent gastroenterologist, well known for developing triple therapy for H. pylori and pioneering faecal transplant therapy in Australia.

He says he has developed an ivermectin-based triple therapy regimen as a potential cure for COVID-19.

The medical director of the Centre for Digestive Diseases (CDD) in Sydney, he argues international data show ivermectin is associated with symptom improvement within 4-6 days and an almost 100% cure rate.

“The government could end the pandemic by openly encouraging GPs to prescribe these TGA-approved medications,” he said last month.